Kimball Solutions’ Q2 earnings missed the mark, with revenue and EPS falling short of expectations, but there’s still reason to stay optimistic. Medical division growth is strong, debt is at its lowest in four years, and global sales are now more evenly distributed across North America, Asia, and Europe. The CEO highlighted gradual growth from their new Indianapolis facility and synergies with Helvoet, while acknowledging shaky EV demand in North America is slowing Automotive recovery. Analysts pressed on margins—confirming they need 8.5% gross margins to hit targets. Investors will watch closely for Medical expansion momentum and whether Automotive can stabilize internationally, especially as inventory and supply chain management become critical next steps.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
